| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |